Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules, 11294-11296 [2021-03751]
Download as PDF
11294
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
information whose disclosure is
restricted by statute.
Submit written comments and
recommendations to OMB for the
proposed information collection within
30 days of publication of this notice to
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
FOR FURTHER INFORMATION CONTACT:
Patrick Yellin, Monitoring, Assistance,
and Media Programs Division, Office of
Compliance, Mail Code 2227A,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460; telephone number: (202) 564–
2970; fax number: (202) 564–0050;
email address: yellin.patrick@epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents, which explain
in detail the information that EPA will
be collecting, are available in the public
docket for this ICR. The docket can be
viewed online at www.regulations.gov,
or in person at the EPA Docket Center,
WJC West, Room 3334, 1301
Constitution Ave. NW, Washington, DC.
The telephone number for the Docket
Center is 202–566–1744. For additional
information about EPA’s public docket,
visit: https://www.epa.gov/dockets.
Abstract: Owners and operators of
affected facilities are required to comply
with reporting and recordkeeping
requirements for the General Provisions
(40 CFR part 63, subpart A), as well as
the applicable standards at 40 CFR part
63, subpart W. This includes submitting
initial notifications, performance tests
and periodic reports and results, and
maintaining records of the occurrence
and duration of any startup, shutdown,
or malfunction in the operation of an
affected facility, or any period during
which the monitoring system is
inoperative. These reports are used by
EPA to determine compliance with
these standards.
Form Numbers: None.
Respondents/affected entities: Epoxy
resin and non-nylon polyamide resin
production facilities.
Respondent’s obligation to respond:
Mandatory (40 CFR part 63, subpart W).
Estimated number of respondents: 7
(total).
Frequency of response: Initially,
quarterly, and semiannually.
Total estimated burden: 3,940 hours
(per year). Burden is defined at 5 CFR
1320.3(b).
Total estimated cost: $476,000 (per
year), which includes $14,000 in
annualized capital/startup and/or
operation & maintenance costs.
Changes in the Estimates: There is no
increase in burden from the most
recently approved ICR as currently
identified in the OMB Inventory of
Approved Burdens. This is due to two
considerations: (1) The regulations have
not changed over the past three years,
and they are not anticipated to change
over the next three years; (2) the growth
rate for this industry is either very low
or non-existent, so there is no
significant change in the overall burden.
However, there is a slight increase in
costs. The operation and maintenance
(O&M) costs have been updated from
1998 dollars to 2019 dollars using the
CEPCI CE Index.
FEDERAL TRADE COMMISSION
Granting of Requests for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
Hart-Scott-Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register.
The following transactions were
granted early termination—on the dates
indicated—of the waiting period
provided by law and the premerger
notification rules. The listing for each
transaction includes the transaction
number and the parties to the
transaction. The Federal Trade
Commission and the Assistant Attorney
General for the Antitrust Division of the
Department of Justice made the grants.
Neither agency intends to take any
action with respect to these proposed
acquisitions during the applicable
waiting period.
Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2021–03793 Filed 2–23–21; 8:45 am]
BILLING CODE 6560–50–P
EARLY TERMINATIONS GRANTED
[01/01/2021 12:00:00 a.m., 01/31/2021 12:00:00 a.m.]
khammond on DSKJM1Z7X2PROD with NOTICES
01/04/2021
20210673
20210692
20210695
20210697
20210698
20210699
20210701
20210702
20210703
20210708
20210709
20210713
20210718
........
........
........
........
........
........
........
........
........
........
........
........
........
G
G
G
G
G
G
G
G
G
G
G
G
G
TransDigm Group Incorporated; AI Convoy (Cayman) Limited; TransDigm Group Incorporated.
Marlin Equity V, L.P.; Luminate Capital Partners, LP; Marlin Equity V, L.P.
Partners Group Access 77 PF LP; New Mountain Partners IV, L.P.; Partners Group Access 77 PF LP.
Aurora Innovation, Inc; Uber Technologies, Inc; Aurora Innovation, Inc.
Uber Technologies, Inc.; Aurora Innovation, Inc; Uber Technologies, Inc.
Howard W. Lutnick; View, Inc.; Howard W. Lutnick.
Humana Inc.; Rajendra K. Bansal; Humana Inc.
Star Peak Energy Transition Corp.; Stem, Inc.; Star Peak Energy Transition Corp.
Columna Datamars S.a.r.l; Datamars Investments S.a.r.l.; Columna Datamars S.a.r.l.
Warburg Pincus Global Growth, L.P.; Tony Olson; Warburg Pincus Global Growth, L.P.
L Catterton IX, L.P.; Truck Hero Holdings, Inc.; L Catterton IX, L.P.
SK Holdings Co., Ltd.; Roivant Sciences Ltd.; SK Holdings Co., Ltd.
AbbVie Inc.; Eiger BioPharmaceuticals, Inc.; AbbVie Inc.
01/11/2021
20210700 ........
20210712 ........
20210719 ........
VerDate Sep<11>2014
G
G
G
Huntsman Corporation; Audax Private Equity Fund IV AIV, L.P.; Huntsman Corporation.
Andrea Pignataro; Flexpoint Fund III, L.P; Andrea Pignataro.
OCM RGCY PT, L.P. ; Drake Kennedy; OCM RGCY PT, L.P.
17:21 Feb 23, 2021
Jkt 253001
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
11295
EARLY TERMINATIONS GRANTED—Continued
[01/01/2021 12:00:00 a.m., 01/31/2021 12:00:00 a.m.]
20210723
20210724
20210732
20210733
20210734
........
........
........
........
........
G
G
G
G
G
Leidos Holdings, Inc; Sumeet Singh; Leidos Holdings, Inc.
Roger S. Penske; Roger S. Penske; Roger S. Penske.
Rhone Partners V L.P.; Gruppo Illy S.p.A; Rhone Partners V L.P.
Fiserv, Inc.; Ondot Systems, Inc.; Fiserv, Inc.
Primoris Services Corporation; Future Infrastructure Holdings, LLC; Primoris Services Corporation.
01/12/2021
20210728
20210729
20210740
20210741
20210742
20210746
20210747
20210748
........
........
........
........
........
........
........
........
G
G
G
G
G
G
G
G
The Veritas Capital Fund VII, L.P.; Northrop Grumman Corporation; The Veritas Capital Fund VII, L.P.
The Veritas Capital Fund VII, L.P.; The Veritas Capital Fund V, L.P.; The Veritas Capital Fund VII, L.P.
Mercuria Energy Group Holding Ltd.; HC2 Holdings, Inc; Mercuria Energy Group Holding Ltd.
CCP III AIV V, L.P. ; New Speedcast Parent; CCP III AIV V, L.P.
Magna International Inc.; Dr. Geeta Gupta and Henrik Fisker; Magna International Inc.
Oaktree Opportunities Fund XI, L.P.; S1 Blocker Buyer, Inc.; Oaktree Opportunities Fund XI, L.P.
The Huron Fund V L.P.; Doug DeClusin; The Huron Fund V L.P.
Partners Group Access 75 PF LP; New Harbor Wedgewood; Partners Group Access 75 PF LP.
01/13/2021
20210737
20210749
20210750
20210752
20210753
20210756
20210757
20210758
20210759
20210762
20210768
20210777
........
........
........
........
........
........
........
........
........
........
........
........
G
G
G
G
G
G
G
G
G
G
G
G
20210778 ........
20210779 ........
20210782 ........
G
G
G
Oshkosh Corporation; James F. Miller; Oshkosh Corporation.
PTC Inc.; JMI Equity Fund VIII–A, L.P.; PTC Inc.
Total SE; Dong Kwan Kim; Total SE.
Alexander Karp; Palantir Technologies Inc.; Alexander Karp.
Stephen Cohen; Palantir Technologies Inc.; Stephen Cohen.
H.I.G. Middle Market LBO Fund III, L.P.; Incline Equity Partners IV, L.P.; H.I.G. Middle Market LBO Fund III, L.P.
Paysafe Limited; Paysafe Group Holdings Limited; Paysafe Limited.
William P. Foley, II; Paysafe Group Holdings Limited; William P. Foley, II.
Cannae Holdings, Inc.; Paysafe Group Holdings Limited; Cannae Holdings, Inc.
Cronos TopCo LP; New Mountain Partners V, L.P.; Cronos TopCo LP.
Murphy USA Inc.; Dean C. Durling; Murphy USA Inc.
Fortress Credit Opportunities Fund V (G) L.P.; Fidentia Fortuna Holdings, Ltd.; Fortress Credit Opportunities Fund V (G)
L.P.
Vesper Healthcare Acquisition Corp.; LCP Edge Holdco, LLC; Vesper Healthcare Acquisition Corp.
United States Steel Corporation; Big River Steel Holdings LLC; United States Steel Corporation.
Jonathan Oringer; Shutterstock, Inc.; Jonathan Oringer.
khammond on DSKJM1Z7X2PROD with NOTICES
01/15/2021
20210173
20210380
20210760
20210775
20210783
20210787
20210790
20210791
20210794
........
........
........
........
........
........
........
........
........
S
G
G
G
G
G
G
G
G
20210795
20210796
20210797
20210798
20210799
20210800
20210801
20210803
20210804
20210805
20210806
20210808
20210843
........
........
........
........
........
........
........
........
........
........
........
........
........
G
G
G
G
G
G
G
G
G
G
G
G
G
VerDate Sep<11>2014
Albertsons Companies, Inc.; KB US Holdings, Inc.; Albertsons Companies, Inc.
Allied Universal Topco LLC; Frank and Kathleen Argenbright; Allied Universal Topco LLC.
ContourGlobal L.P.; Harbert Power Fund V, LLC; ContourGlobal L.P.
Amphenol Corporation; MTS Systems Corporation ; Amphenol Corporation.
KPS Special Situations Fund IV, LP; Ernest W. Giddens; KPS Special Situations Fund IV, LP.
TCV X, L.P.; Newsela Inc.; TCV X, L.P.
Kemper Corporation; American Access Group, LLC; Kemper Corporation.
Silver Spike Acquisition Corp.; WM Holding Company, LLC; Silver Spike Acquisition Corp.
Charlesbank Equity Fund IX, Limited Partnership; SPC Partners V, L.P.; Charlesbank Equity Fund IX, Limited Partnership.
LPL Financial Holdings Inc.; Macquarie Group Limited; LPL Financial Holdings Inc.
American Securities Partners VIII, L.P.; Beacon Roofing Supply, Inc.; American Securities Partners VIII, L.P.
Koninklijke Philips N.V.; Francisco Partners Agility, L. P.; Koninklijke Philips N.V.
The Resolute Fund V, L.P.; Madison Dearborn Capital Partners VII–A, L.P.; The Resolute Fund V, L.P.
Stillfront Group AB; Super Free Games, Inc.; Stillfront Group AB.
United Therapeutics Corporation; Y-mAbs Therapeutics, Inc.; United Therapeutics Corporation.
Temasek Holdings (Private) Limited; Kazuhide Nakano; Temasek Holdings (Private) Limited.
Macquarie Group Limited; Waddell & Reed Financial, Inc.; Macquarie Group Limited.
TC Energy Corporation; TC PipeLines, LP; TC Energy Corporation.
The Veritas Capital Fund VII, L.P.; HMS Holdings Corp.; The Veritas Capital Fund VII, L.P.
Matthew Rabinowitz; Natera, Inc.; Matthew Rabinowitz.
Cerner Corporation; Bain Capital Europe Fund V, SCSp; Cerner Corporation.
George Archos; Majesta Minerals, Inc.; George Archos.
17:21 Feb 23, 2021
Jkt 253001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
E:\FR\FM\24FEN1.SGM
24FEN1
11296
Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
FOR FURTHER INFORMATION CONTACT:
Theresa Kingsberry (202–326–3100),
Program Support Specialist, Federal
Trade Commission Premerger
Notification Office, Bureau of
Competition, Room CC–5301,
Washington, DC 20024.
By direction of the Commission.
Joel Christie,
Acting Secretary.
[FR Doc. 2021–03751 Filed 2–23–21; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE P
[FR Doc. 2021–03744 Filed 2–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Agency for Toxic Substances and
Disease Registry
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE21–002: Research Grants to Develop
or Identify Effective Strategies to
Prevent Overdose Involving Illicit
Stimulants and Polysubstance Use
Involving Stimulants.
Dates: June 15–16, 2021.
Times: 8:30 a.m.–5:00 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
VerDate Sep<11>2014
17:21 Feb 23, 2021
Jkt 253001
[60Day–20–0051; Docket No. ATSDR–2020–
0005]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), as part of its continuing effort
to reduce public burden and maximize
the utility of government information,
invites the general public and other
Federal agencies the opportunity to
comment on a proposed and/or
continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘Assessment of
Chemical Exposures (ACE)
Investigations.’’ The purpose of ACE
Investigations is to focus on performing
rapid epidemiological assessments to
assist state, regional, local, or tribal
health departments (the requesting
agencies) to respond to or prepare for
acute environmental incidents.
DATES: ATSDR must receive written
comments on or before April 26, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. ATSDR–2020–
0005 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
SUMMARY:
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Docket Number. ATSDR will post,
without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
Proposed Project
Assessment of Chemical Exposures
(ACE) Investigations (OMB Control No.
0923–0051)—Reinstatement with
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11294-11296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03751]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Granting of Requests for Early Termination of the Waiting Period
Under the Premerger Notification Rules
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II
of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires
persons contemplating certain mergers or acquisitions to give the
Federal Trade Commission and the Assistant Attorney General advance
notice and to wait designated periods before consummation of such
plans. Section 7A(b)(2) of the Act permits the agencies, in individual
cases, to terminate this waiting period prior to its expiration and
requires that notice of this action be published in the Federal
Register.
The following transactions were granted early termination--on the
dates indicated--of the waiting period provided by law and the
premerger notification rules. The listing for each transaction includes
the transaction number and the parties to the transaction. The Federal
Trade Commission and the Assistant Attorney General for the Antitrust
Division of the Department of Justice made the grants. Neither agency
intends to take any action with respect to these proposed acquisitions
during the applicable waiting period.
Early Terminations Granted
[01/01/2021 12:00:00 a.m., 01/31/2021 12:00:00 a.m.]
------------------------------------------------------------------------
------------------------------------------------------------------------
01/04/2021
------------------------------------------------------------------------
20210673................... G TransDigm Group
Incorporated; AI Convoy
(Cayman) Limited; TransDigm
Group Incorporated.
20210692................... G Marlin Equity V, L.P.;
Luminate Capital Partners,
LP; Marlin Equity V, L.P.
20210695................... G Partners Group Access 77 PF
LP; New Mountain Partners
IV, L.P.; Partners Group
Access 77 PF LP.
20210697................... G Aurora Innovation, Inc; Uber
Technologies, Inc; Aurora
Innovation, Inc.
20210698................... G Uber Technologies, Inc.;
Aurora Innovation, Inc;
Uber Technologies, Inc.
20210699................... G Howard W. Lutnick; View,
Inc.; Howard W. Lutnick.
20210701................... G Humana Inc.; Rajendra K.
Bansal; Humana Inc.
20210702................... G Star Peak Energy Transition
Corp.; Stem, Inc.; Star
Peak Energy Transition
Corp.
20210703................... G Columna Datamars S.a.r.l;
Datamars Investments
S.a.r.l.; Columna Datamars
S.a.r.l.
20210708................... G Warburg Pincus Global
Growth, L.P.; Tony Olson;
Warburg Pincus Global
Growth, L.P.
20210709................... G L Catterton IX, L.P.; Truck
Hero Holdings, Inc.; L
Catterton IX, L.P.
20210713................... G SK Holdings Co., Ltd.;
Roivant Sciences Ltd.; SK
Holdings Co., Ltd.
20210718................... G AbbVie Inc.; Eiger
BioPharmaceuticals, Inc.;
AbbVie Inc.
------------------------------------------------------------------------
01/11/2021
------------------------------------------------------------------------
20210700................... G Huntsman Corporation; Audax
Private Equity Fund IV AIV,
L.P.; Huntsman Corporation.
20210712................... G Andrea Pignataro; Flexpoint
Fund III, L.P; Andrea
Pignataro.
20210719................... G OCM RGCY PT, L.P. ; Drake
Kennedy; OCM RGCY PT, L.P.
[[Page 11295]]
20210723................... G Leidos Holdings, Inc; Sumeet
Singh; Leidos Holdings,
Inc.
20210724................... G Roger S. Penske; Roger S.
Penske; Roger S. Penske.
20210732................... G Rhone Partners V L.P.;
Gruppo Illy S.p.A; Rhone
Partners V L.P.
20210733................... G Fiserv, Inc.; Ondot Systems,
Inc.; Fiserv, Inc.
20210734................... G Primoris Services
Corporation; Future
Infrastructure Holdings,
LLC; Primoris Services
Corporation.
------------------------------------------------------------------------
01/12/2021
------------------------------------------------------------------------
20210728................... G The Veritas Capital Fund
VII, L.P.; Northrop Grumman
Corporation; The Veritas
Capital Fund VII, L.P.
20210729................... G The Veritas Capital Fund
VII, L.P.; The Veritas
Capital Fund V, L.P.; The
Veritas Capital Fund VII,
L.P.
20210740................... G Mercuria Energy Group
Holding Ltd.; HC2 Holdings,
Inc; Mercuria Energy Group
Holding Ltd.
20210741................... G CCP III AIV V, L.P. ; New
Speedcast Parent; CCP III
AIV V, L.P.
20210742................... G Magna International Inc.;
Dr. Geeta Gupta and Henrik
Fisker; Magna International
Inc.
20210746................... G Oaktree Opportunities Fund
XI, L.P.; S1 Blocker Buyer,
Inc.; Oaktree Opportunities
Fund XI, L.P.
20210747................... G The Huron Fund V L.P.; Doug
DeClusin; The Huron Fund V
L.P.
20210748................... G Partners Group Access 75 PF
LP; New Harbor Wedgewood;
Partners Group Access 75 PF
LP.
------------------------------------------------------------------------
01/13/2021
------------------------------------------------------------------------
20210737................... G Oshkosh Corporation; James
F. Miller; Oshkosh
Corporation.
20210749................... G PTC Inc.; JMI Equity Fund
VIII-A, L.P.; PTC Inc.
20210750................... G Total SE; Dong Kwan Kim;
Total SE.
20210752................... G Alexander Karp; Palantir
Technologies Inc.;
Alexander Karp.
20210753................... G Stephen Cohen; Palantir
Technologies Inc.; Stephen
Cohen.
20210756................... G H.I.G. Middle Market LBO
Fund III, L.P.; Incline
Equity Partners IV, L.P.;
H.I.G. Middle Market LBO
Fund III, L.P.
20210757................... G Paysafe Limited; Paysafe
Group Holdings Limited;
Paysafe Limited.
20210758................... G William P. Foley, II;
Paysafe Group Holdings
Limited; William P. Foley,
II.
20210759................... G Cannae Holdings, Inc.;
Paysafe Group Holdings
Limited; Cannae Holdings,
Inc.
20210762................... G Cronos TopCo LP; New
Mountain Partners V, L.P.;
Cronos TopCo LP.
20210768................... G Murphy USA Inc.; Dean C.
Durling; Murphy USA Inc.
20210777................... G Fortress Credit
Opportunities Fund V (G)
L.P.; Fidentia Fortuna
Holdings, Ltd.; Fortress
Credit Opportunities Fund V
(G) L.P.
20210778................... G Vesper Healthcare
Acquisition Corp.; LCP Edge
Holdco, LLC; Vesper
Healthcare Acquisition
Corp.
20210779................... G United States Steel
Corporation; Big River
Steel Holdings LLC; United
States Steel Corporation.
20210782................... G Jonathan Oringer;
Shutterstock, Inc.;
Jonathan Oringer.
------------------------------------------------------------------------
01/15/2021
------------------------------------------------------------------------
20210173................... S Albertsons Companies, Inc.;
KB US Holdings, Inc.;
Albertsons Companies, Inc.
20210380................... G Allied Universal Topco LLC;
Frank and Kathleen
Argenbright; Allied
Universal Topco LLC.
20210760................... G ContourGlobal L.P.; Harbert
Power Fund V, LLC;
ContourGlobal L.P.
20210775................... G Amphenol Corporation; MTS
Systems Corporation ;
Amphenol Corporation.
20210783................... G KPS Special Situations Fund
IV, LP; Ernest W. Giddens;
KPS Special Situations Fund
IV, LP.
20210787................... G TCV X, L.P.; Newsela Inc.;
TCV X, L.P.
20210790................... G Kemper Corporation; American
Access Group, LLC; Kemper
Corporation.
20210791................... G Silver Spike Acquisition
Corp.; WM Holding Company,
LLC; Silver Spike
Acquisition Corp.
20210794................... G Charlesbank Equity Fund IX,
Limited Partnership; SPC
Partners V, L.P.;
Charlesbank Equity Fund IX,
Limited Partnership.
20210795................... G LPL Financial Holdings Inc.;
Macquarie Group Limited;
LPL Financial Holdings Inc.
20210796................... G American Securities Partners
VIII, L.P.; Beacon Roofing
Supply, Inc.; American
Securities Partners VIII,
L.P.
20210797................... G Koninklijke Philips N.V.;
Francisco Partners Agility,
L. P.; Koninklijke Philips
N.V.
20210798................... G The Resolute Fund V, L.P.;
Madison Dearborn Capital
Partners VII-A, L.P.; The
Resolute Fund V, L.P.
20210799................... G Stillfront Group AB; Super
Free Games, Inc.;
Stillfront Group AB.
20210800................... G United Therapeutics
Corporation; Y-mAbs
Therapeutics, Inc.; United
Therapeutics Corporation.
20210801................... G Temasek Holdings (Private)
Limited; Kazuhide Nakano;
Temasek Holdings (Private)
Limited.
20210803................... G Macquarie Group Limited;
Waddell & Reed Financial,
Inc.; Macquarie Group
Limited.
20210804................... G TC Energy Corporation; TC
PipeLines, LP; TC Energy
Corporation.
20210805................... G The Veritas Capital Fund
VII, L.P.; HMS Holdings
Corp.; The Veritas Capital
Fund VII, L.P.
20210806................... G Matthew Rabinowitz; Natera,
Inc.; Matthew Rabinowitz.
20210808................... G Cerner Corporation; Bain
Capital Europe Fund V,
SCSp; Cerner Corporation.
20210843................... G George Archos; Majesta
Minerals, Inc.; George
Archos.
------------------------------------------------------------------------
[[Page 11296]]
FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry (202-326-3100),
Program Support Specialist, Federal Trade Commission Premerger
Notification Office, Bureau of Competition, Room CC-5301, Washington,
DC 20024.
By direction of the Commission.
Joel Christie,
Acting Secretary.
[FR Doc. 2021-03751 Filed 2-23-21; 8:45 am]
BILLING CODE P